Metrasens Files Patent Infringement Case in Shanghai Intellectual Property Court against Nanjing Cloud Magnet Electronic Technology Limited

Tuesday, August 13, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Metrasens, a global leader in MRI safety solutions, has commenced a new patent infringement case against Nanjing Cloud Magnet Electronic Technology Limited in Shanghai Intellectual Property Court.

MALVERN, England, Aug. 13, 2019 /PRNewswire-PRWeb/ -- Metrasens, a global leader of MRI Safety solutions for healthcare

facilities, announces that on 5th August 2019 it filed a new patent infringement case with Shanghai Intellectual Property Court against Nanjing Cloud Magnet Electronic Technology Limited.

Metrasens is a leading provider of advanced magnetic detection technologies. Founded in the UK, Metrasens has become a global industry leader in the provision of patient safety solutions to MRI facilities. Its FerroguardŪ products have built a reputation as trustworthy ferromagnetic detection systems (FMDS) and are in use in 36 countries.

Metrasens has previously commenced action in China, in Nanjing Intermediate People's Court, against Nanjing Cloud Magnet Electronic Technology Limited ???????????? ("Cloud Magnet") and its affiliate Nanjing Haole Technology Co., Ltd ?????????? ("NH") for infringement of Metrasens' granted patents, and copyright materials.

The patent infringement case alleges Cloud Magnet has continued to actively and publicly promote its products which we believe infringe Metrasens' patents granted in China, including in particular, the promotion and offer to sell these products at an exhibition in Shanghai. Consequently, Metrasens has filed a new patent infringement case with the Shanghai Intellectual Property Court on 5 August 2019 (Case Re: (2019) Hu 73 ZhiMin Chu No. 599). We trust Shanghai Intellectual Property Court, as one of the specialized intellectual property courts in China, will render a decision according to the laws. In order to avoid parallel trials, we are going to combine the infringement asserted at the Nanjing into the case to be tried by the specialist Shanghai Intellectual Property Court and withdraw the patent infringement case with the Nanjing Court.

Metrasens greatly values the relationships that it has developed with the Chinese radiology community through its adoption of Ferroguard MRI safety systems over the past six years. Similarly, it greatly respects the development within China of new technologies to advance the goal of making MRI facilities as safe as possible for all patients and staff. However, Metrasens values its intellectual property rights and will continue to take all necessary legal and commercial steps to protect its proprietary technology and patents.

About Metrasens Metrasens is the world's leading provider of advanced magnetic detection technologies. Our innovative products are designed to address deficiencies in conventional screening methods, to make us all safer and more secure. Our mission is to take great science from the laboratory and use it to create revolutionary, award-winning products which meet the real needs of our customers. Metrasens' core technologies have an extremely wide range of potential applications. Innovation is at the core of everything we do – from research and development, through to customer service and training.

Metrasens has grown rapidly to become a dynamic international business, and the acknowledged leader in our chosen markets. Our Technology Centre and manufacturing facility are located in the UK, and we have established a global network of distributors. Our developments continue to enable new customers, working in increasingly complex environments, to achieve higher levels of safety and security.


SOURCE Metrasens

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store